Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Product and Service [Axis]
TNX-4200 [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Products 1, 2 and 3 [Member]
Concentration Risk Benchmark [Axis]
Revenue Benchmark [Member]
Concentration Risk Type [Axis]
Product Concentration Risk [Member]
Products 1 and 2 [Member]
Customer [Axis]
Customer 1 [Member]
Accounts Receivable [Member]
Customer Concentration Risk [Member]
Customer 2 [Member]
Customer 3 [Member]
Customer 4 [Member]
Customer 5 [Member]
Long-Lived Asset, Class [Axis]
Building [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Land Improvements and Lab Equipment [Member]
Computer Equipment [Member]
Furniture and All Other Equipment [Member]
Leasehold Improvements [Member]
Nature of Expense [Axis]
Direct expenses – TNX - 102 SL [Member]
Direct expenses – TNX - 801 [Member]
Direct expenses – TNX - 1500 [Member]
Direct expenses – TNX - 1900 [Member]
Direct expenses – TNX - 4200 [Member]
Direct expenses – TNX - 4800 [Member]
Direct expenses – Other programs [Member]
Internal staffing, overhead and other [Member]
Antidilutive Securities [Axis]
Warrant [Member]
Share-Based Payment Arrangement, Option [Member]
Land [Member]
Land Improvements [Member]
Office furniture and equipment [Member]
Laboratory equipment [Member]
Cash and Cash Equivalents [Axis]
Cash Equivalents [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Debt Instrument [Axis]
Term Loan [Member]
Tonmya [Member]
Zembrace Symtouch [Member]
Tosymra [Member]
SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]
Gross-to-Net Allowances [Member]
Location, Statement of Financial Position, Balance [Axis]
Business Combination [Axis]
Upsher-Smith Laboratories, LLC [Member]
Business Combination, Contingent Consideration, Type [Axis]
Earn-Out Range 1 [Member]
Earn-Out Range 2 [Member]
Earn-Out Range 3 [Member]
Earn-Out Range 4 [Member]
Earn-Out Range 5 [Member]
Sales Milestones [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Purchase Agreement [Member]
Related and Nonrelated Parties [Axis]
2025 Lincoln Park Transaction [Member]
2025 Sales Agreement [Member]
Alliance Global Partners [Member]
2024 Sales Agreement [Member]
Share Repurchase Program [Axis]
2024 Share Repurchase Program [Member]
Plan Name [Axis]
Amended and Restated 2020 Plan [Member]
10% or more Shareholder [Member]
Award Type [Axis]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Title and Position [Axis]
Director [Member]
Executive Officer [Member]
Location, Statement of Income, Balance [Axis]
2025 Employee Stock Purchase Plan [Member]
2023 Employee Stock Purchase Plan [Member]
Employee Stock Purchase Plan [Member]
2022 Employee Stock Purchase Plan [Member]
Class of Warrant or Right [Axis]
Warrant One [Member]
Warrant Two [Member]
Warrant Three [Member]
Warrant Four [Member]
Warrant Five [Member]
Warrant Six [Member]
Warrant Seven [Member]
Warrant Eight [Member]
Warrants One [Member]
Warrants Two [Member]
Warrants Three [Member]
Other Commitments [Axis]
Research Organizations [Member]
License Agreements [Member]
Defined Contribution Plan [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity common stock, shares outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Accounts receivable, net
Inventory
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Operating lease right-to-use assets
Other non-current assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Lease liability, short term
Total current liabilities
Lease liability, long term
Total liabilities
Commitments (See Note 16)
Stockholders’ equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized, 0 shares issued and outstanding - as of both March 31, 2026 and December 31, 2025
Common stock, $0.001 par value; 1,000,000,000 shares authorized; 14,205,401 and 12,788,069 shares issued and outstanding as of March 31, 2026, and December 31, 2025, respectively and 5,883 shares to be issued as of December 31, 2025
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, par value (in dollars per share)
Preferred stock, authorized
Preferred stock, issued
Preferred stock, outstanding
Common stock, par value (in dollars per share)
Common stock, authorized
Common stock, issued
Common stock, outstanding
Common stock, to be issued
Income Statement [Abstract]
REVENUES:
Product revenue, net
COSTS AND EXPENSES:
Cost of sales
Research and development
Selling general and administrative
Total operating expenses
Operating loss
Grant income
Loss on Extinguishment of Debt
Interest income
Other expense, net
Net loss available to common stockholders
Net loss to common stockholders per common share, basic
Net loss to common stockholders per common share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted
Net loss
Other comprehensive gain (loss):
Foreign currency translation gain (loss)
Total other comprehensive gain (loss)
Comprehensive loss
Statement [Table]
Statement [Line Items]
Beginning balance, value
Balance, at beginning (in shares)
Issuance of common stock under the At-the-Market, net of issuance costs of $676
Issuance of common stock under At-the-market offering, net of issuance costs (in shares)
Repurchase of common stock under share repurchase program, including transactional expenses of $8
Repurchase of common stock under share repurchase program, including transactional expenses of $8 (in shares)
Issuance of common stock under At-the-Market, net of transactional expenses of $2,182
Issuance of common stock under At-the-Market, net of transactional expenses of $2,182 (in shares)
Employee stock purchase plan (ESPP)
Employee stock purchase plan (ESPP) (in shares)
Stock-based compensation
Foreign currency translation loss
Ending balance, value
Balance, at ending (in shares)
Statement of Stockholders' Equity [Abstract]
Repurchase of common stock under share repurchase program, transactional expenses
Issuance of common stock under At-the-Market, transactional expenses
Statement of Cash Flows [Abstract]
CASH FLOWS FROM OPERATING ACTIVITIES:
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Amortization of debt discount
Loss on extinguishment of debt
Stock-based compensation
Changes in operating assets and liabilities:
Accounts receivable, net
Prepaid expenses and other
Other non-current assets
Inventory
Accounts payable
Operating lease liabilities and ROU asset, net
Accrued expenses and other current liabilities
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of term loan
Repurchase of common stock
Proceeds from ESPP
Proceeds, net issuance costs paid of $676 and $2,270, from sale of common stock
Net cash provided by financing activities
Effect of currency rate change on cash
Net (decrease) increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash beginning of the period
Cash, cash equivalents and restricted cash end of period
Supplemental disclosures of cash flow information:
Interest paid
Purchases of property and equipment including in accounts payable and accrued liabilities
Issuance costs paid for sale of common stock
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Trading Arrangements, by Individual [Table]
Trading Arrangement [Axis]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BUSINESS
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES
Inventory Disclosure [Abstract]
INVENTORY
Property, Plant, and Equipment [Abstract]
PROPERTY AND EQUIPMENT, NET
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS
Other Balance Sheet Information
OTHER BALANCE SHEET INFORMATION
Debt Disclosure [Abstract]
DEBT FINANCING
Equity [Abstract]
STOCKHOLDERS’ EQUITY
Revenue from Contract with Customer [Abstract]
REVENUES
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]
ASSET PURCHASE AGREEMENT WITH UPSHER-SMITH
Sale And Purchase Of Common Stock
SALE AND PURCHASE OF COMMON STOCK
Share-Based Payment Arrangement [Abstract]
STOCK-BASED COMPENSATION
Warrants To Purchase Common Stock
WARRANTS TO PURCHASE COMMON STOCK
Leases
LEASES
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS
Subsequent Events [Abstract]
SUBSEQUENT EVENTS
Interim financial statements
Risks and uncertainties
Use of estimates
Segment Information and Concentrations
Cash, Cash Equivalents and Restricted Cash
Accounts Receivable, net
Concentration of Credit Risk
Inventories
Property and equipment
Intangible assets, net
Impairment testing of long-lived assets
Leases
Revenue Recognition
Research and Development Costs
Government Grants
Advertising and Promotion Costs
Stock-based Compensation
Foreign Currency Translation
Comprehensive Income (Loss)
Income Taxes
Per Share Data
Recently Adopted and Issued Accounting Pronouncements
Information about significant segment expenses regularly provided to the CODM is as follows (in thousands):
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows:
Potentially dilutive securities excluded from the computation of basic and diluted net loss per share, as of March 31, 2026, and 2025, are as follows:
The components of inventory consisted of the following (in thousands):
Property and equipment, net consisted of the following (in thousands):
The following table provides the gross carrying amount and accumulated amortization for each major class of intangible asset:
Components of selected captions in the consolidated balance sheets consist of:
The Company’s net product revenues are summarized below:
The Company repurchased the following capital stock:
A summary of the stock option activity and related information for the Plans for the three months ended March 31, 2026, is as follows:
The assumptions used in the valuation of stock options granted during the three months ended March 31, 2026, and 2025 were as follows:
The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company at March 31, 2026:
At March 31, 2026, future minimum lease payments for operating leases with non-cancelable terms of more than one year were as follows (in thousands):
Other information related to leases is as follows:
Nature of Operation, Product Information, Concentration of Risk [Table]
Product Information [Line Items]
Development Contract
Working capital
Net proceeds
Number of Operating Segments
Revenue
Concentration Risk, Percentage
Cash equivalents
Restricted cash
Allowance for credit losses
Estimated useful life of property and equipment
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]
Depreciation and amortization expense
Intangible Asset, Finite-Lived, Amortization Expense
Contractual payment terms
Grant amount awarded
Advertising Expense
Interim Period, Costs Not Allocable [Table]
Interim Period, Costs Not Allocable [Line Items]
Research and development expenses:
Total research & development
Change
Restricted cash
Total
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Totals
Raw Materials
Work-in-process
Finished Goods
Total Inventory
Other non-current assets
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Property and equipment gross
Less: Accumulated depreciation and amortization
Property and equipment, net
Internet domain rights
Total intangible assets, net
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Cash equivalents
Components Of Selected Captions In Consolidated Balance Sheets Consist Of
Prepaid expenses and other current assets:
Contract research-related
Prepaid Inventory
Prescription drug user fee
Taxes
Insurance
Professional fees and other
Other non-current assets:
Amounts held in escrow
Inventory
Security deposits
Accrued expenses and other current liabilities:
Contract research-related
Compensation and compensation-related
Gross-to-net deductions
Professional fees and other
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Debt term
Principal amount
Debt maturity date
Discount percentage
Debt discount
Repayment of loan
Prepayment fee
Reverse stock split
Nasdaq minimum bid requirement
Period of business days of compliance with minimum bid requirement
Disaggregation of Revenue [Table]
Disaggregation of Revenue [Line Items]
Total product revenues
Gross-to-net allowances
Gross-to-net allowances, adjustment
Additional revenue recognized
Business Combination [Table]
Business Combination [Line Items]
Earm-out payment percentage
Earm-out net sales
Earm-out payment percentage reduction upon entry of generic product
Additional royalty percentage
Additional royalty percentage for U.S. patent
Additional royalty payment period
Maximum payment for sales milestones
Annual worldwide net sales for milestone
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Common stock purchase
Number of shares issued
Offering price per agreement
Commission to agent
Share repurchase authorized amount
Shares repurchased
Price per share
Cost of repurchased shares
Company Repurchased Following Capital Stock
Total cost of repurchased shares (in thousands)
Weighted average price per share
Outstanding at beginning
Outstanding at beginning
Weighted average remaining contractual term
Outstanding, Aggregagte Intrinsic Value
Grants
Grants
Forfeitures or expirations
Forfeitures or expirations
Outstanding at end
Outstanding at end
Outstanding, Aggregagte Intrinsic Value
Exercisable at end
Exercisable at end
Exercisable at end
Exercisable, Aggregagte Intrinsic Value
Risk-free interest rate - Minimum
Risk-free interest rate - Maximum
Risk-free interest rate
Expected term of option
Expected stock price volatility - minimum
Expected stock price volatility - maximum
Expected stock price volatility
Expected dividend yield
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized
Percentage of additional shares authorized
Number of additional shares authorized
Percent of fair value of common stock at grant date
Expiration period
Number of shares available for future grants
Weighted average grant date fair value of options (in dollars per share)
Vesting percentage
Vesting period
Service period
Stock-based compensation expense
Unrecognized compensation cost
Unrecognized compensation cost, recognition period
Transfer to additional paid in capital
Employee stock purchase plan (in shares)
Class of Warrant or Right [Table]
Class of Warrant or Right [Line Items]
Exercise price (in dollars per share)
Number outstanding
Expiration date
Number of warrants that became exercisable
Number of warrants that became exercisable upon FDA acceptance of NDA filing
Number of warrants expired
Exercise price of warrants expired (in dollars per share)
At March 31 2026 Future Minimum Lease Payments For Operating Leases With Non-cancelable Terms Of More Than One Year Were As Follows In Thousands
Remainder of 2026
2027
2028
2029
2030
Included interest
Other Information Related To Leases Is As Follows
Operating cash flow from operating leases
Weighted average remaining lease term operating leases
Weighted average discount rate operating leases
Right-of-use assets, net
Total lease liability
Lease liability, net of current portion
Lease liability, current
Operating lease expense
Other Commitments [Table]
Other Commitments [Line Items]
Outstanding commitments
Development milestone fees payable
Commercial achievement milestone fees payable
Employer matching contribution
Maximum annual contributions per employee
Employer contributions
Subsequent Event [Table]
Subsequent Event [Line Items]
The element represents stock issued during period value new issues at the market.
The element represents adjustments to additional paid in capital stock issued issuance costs at the market.
The elements represents stock issued during period shares new issues at the market.
Amount of transactional expenses related to repurchase of common stock under share repurchase program.
Amount of working capital as of reporting date.
Products 1 and 2.
Customer 1 [Member]
Customer 2 [Member]
Customer 3 [Member]
Customer 4 [Member]
Customer 5 [Member]
Land Improvements and Lab Equipment.
The element represents furniture and all other equipment member.
Amount of grant awarded.
The entire disclosure of other balance sheet information.
Carrying value as of the balance sheet date of compensation and compensation-related expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Carrying value as of the balance sheet date of Professional fees and other related expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Term Loan.
Issue discount percentage for funds borrowed, under the debt agreement.
The minimum bid price requirement per share for continued listing per Nasdaq rule.
Upsher-Smith Laboratories, LLC.
For earn-out arrangement recognized in connection with a business combination, this element represents the quarterly earn-out payment percentage of annual net sales.
Tosymra [Member]
Earn-Out Range 1 [Member]
For earn-out arrangement recognized in connection with a business combination, this element represents the annual net sales used to determine quarterly earn-out payments.
Earn-Out Range 2 [Member]
Earn-Out Range 3 [Member]
Earn-Out Range 4 [Member]
Earn-Out Range 5 [Member]
Zembrace Symtouch [Member]
For earn-out arrangement recognized in connection with a business combination, this element represents the reduction of quarterly earn-out payment percentage upon entry of a generic version of product.
For royalty arrangement recognized in connection with a business combination, additional royalty percentage on net sales from the first commercial sale in the applicable country or for as long as the manufacture, use or sale in such country is covered by a valid claim of a licensed patent,
For royalty arrangement recognized in connection with a business combination, additional royalty percentage if a patent containing certain claims issues in the U.S. in addition to royalty on net sales from the first commercial sale in the applicable country or for as long as the manufacture, use or sale in such country is covered by a valid claim of a licensed patent,
For royalty arrangement recognized in connection with a business combination, period for payment of royalty from the first commercial sale in the applicable country or for as long as the manufacture, use or sale in such country is covered by a valid claim of a licensed patent.
Sales Milestones [Member]
The entire disclosure of sale and purchase of common stock.
The element represents offering price per agreement.
The element represents alliance global partners member.
The element represents sales agent commission percentage.
Purchase Agreement [Member]
2024 Share Repurchase Program.
Amended and Restated 2020 Plan
Percentage of additional shares authorized for issuance under share-based payment arrangement.
10% or more Shareholder.
2023 Employee Stock Purchase Plan.
Employee Stock Purchase Plan.
2022 Employee Stock Purchase Plan.
The entire disclosure of stock warrants.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Expiration date of warrants or rights outstanding.
The exercise price of expired warrants.
Warrants One [Member]
Warrants Two [Member]
Warrants Three [Member]
Tabular disclosure of other information related to leases.
The element represents research organizations member.
Defined Contribution Plan.
The element represents stock issued during period value new issues at the market.
Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.
Office furniture and equipment [Member]
Laboratory equipment [Member]
Number of new stock issued under At-the-Market offerings during the period.
Prepaid Prescription Drug User Fee Act fees.
Tonmya.
Common Stock Purchase.
2025 Lincoln Park Transaction [Member]
2025 Sales Agreement [Member]
2024 Sales Agreement [Member]
Tabular disclosure of share repurchases.
2025 Employee Stock Purchase Plan.
Milestone fees payable based on potential achievement of certain development milestones.
License Agreements.
Milestone fees payable based on potential achievement of certain commercial achievements.
Amount of contributions made by an employer to a defined contribution plan.
Products 1, 2 and 3.
Disclosure of accounting policy for interim financial statements.
Period of business days of compliance with minimum bid price requirement per share for continued listing per Nasdaq Listing Rule.
Amount of announced development contract.
TNX-4200.
Gross-to-Net Allowances.
Amount of annual worldwide net sales for milestone.
Net number of non-option equity instruments that became exercisable.
Net number of non-option equity instruments that became exercisable upon FDA acceptance of NDA filing.
Total amount of inventory, including current and non-current inventories.
Direct expenses – TNX - 102 SL.
Amount of increase (decrease) in research and development expense during the period.
Direct expenses – TNX - 801.
Direct expenses – TNX - 1500.
Direct expenses – TNX - 1900.
Direct expenses – TNX - 4200.
Direct expenses – TNX - 4800.
Direct expenses – Other programs.
Internal staffing, overhead and other.
Amount of revenue recognized for valudation allowances and reservies adjustments.
Useful Life, Shorter of Lease Term or Asset Utility [Member]
Assets, Current
Assets
Liabilities, Current
Liabilities
Equity, Attributable to Parent
Liabilities and Equity
Costs and Expenses
Operating Income (Loss)
Net Income (Loss) Available to Common Stockholders, Basic
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
Stock Repurchased and Retired During Period, Value
Share-Based Payment Arrangement, Noncash Expense
Increase (Decrease) in Accounts Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Noncurrent Assets
Increase (Decrease) in Inventories
Increase (Decrease) in Accounts Payable, Trade
Increase (Decrease) in Other Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Goodwill and Intangible Assets, Intangible Assets, Indefinite-Lived, Policy [Policy Text Block]
Lessee, Leases [Policy Text Block]
Restricted Cash
Inventory Current and Noncurrent
Inventory, Noncurrent
Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization
Cash and Cash Equivalents, Fair Value Disclosure
Contract with Customer, Liability, Current
Professional Fees And Other Accrued Liabilities Current
SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount